Effect of insulin on FDG-PET/CT imaging
Author:
Liao Hao Ting (Jacky)
Publisher
Radiopaedia.org
Reference4 articles.
1. Glaudemans A, de Vries E, Galli F, Dierckx R, Slart R, Signore A. The Use of (18)F-FDG-PET/CT for Diagnosis and Treatment Monitoring of Inflammatory and Infectious Diseases. Clin Dev Immunol. 2013;2013:623036.
2. Surasi D, Bhambhvani P, Baldwin J, Almodovar S, O'Malley J. 18F-FDG PET and PET/CT Patient Preparation: A Review of the Literature. J Nucl Med Technol. 2014;42(1):5-13.
3. Rallapeta R, Manthri R, Kalawat T, Sachan A, Lakshmi A, Hulikal N. Utility of Short-Acting Intravenous Insulin Therapy in Preparation of F-18 Fluorodeoxyglucose Positron Emission Tomography Computed Tomography Scan in Cancer Patients Incidentally Detected with High Blood Glucose Levels on the Day of Test. Indian J Nucl Med. 2020;35(2):110-5.
4. Roy F, Beaulieu S, Boucher L, Bourdeau I, Cohade C. Impact of Intravenous Insulin on 18F-FDG PET in Diabetic Cancer Patients. J Nucl Med. 2009;50(2):178-83.